362 studies found for:    diabetes and type 1 and open and active | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Disease
Interventions: Drug: Liraglutide;   Drug: Sitagliptin
22 Unknown  Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy
Condition: Treatment of Type I Diabetes Mellitus.
Intervention: Biological: Biological
23 Recruiting A 24 Week International, Open-Label Trial With a 28 Week Extension to Evaluate the Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects With Type 2 Diabetes on Metformin With or Without Sulfonylurea Therapy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Saxagliptin;   Drug: Dapagliflozin;   Drug: Glargine insulin
24 Recruiting Pilot Prospective CGM Quality Improvement (QI) Project
Condition: Diabetes Mellitus, Type I
Interventions: Device: Dexcom G4 Platinum CGM system;   Device: Dexcom G4 Platinum CGM system with Share
25 Recruiting The Mobile Diabetes Mgmt. Study With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Other: Traditional care with paper;   Device: Health-on G App. + Physician Web
26 Recruiting Description of Socio-cognitive and Clinic Changes for Type 1 Diabetes Adolescents Cohort With Therapeutic Patient Education Program
Condition: Type 1 Diabetes
Intervention: Other: Questionnaires and audio-tape interviews
27 Not yet recruiting Long Term CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections
Condition: Diabetes Mellitus Type 1
Intervention: Device: Dexcom G4 or later generation
28 Unknown  Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study
Condition: Type 1 Diabetes
Interventions: Procedure: Isolated Pancreas Transplant;   Drug: Intensive Insulin Therapy
29 Unknown  Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA)
Condition: Latent Autoimmune Diabetes in Adults LADA
Interventions: Drug: NovoMix 30;   Drug: Tablet treatment
30 Recruiting FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)
Condition: Type 1 Diabetes
Intervention: Behavioral: FL3X: Flexible Lifestyle Empowering Change
31 Unknown  Comparing Long-acting Insulins During Exercise in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Insulin glargine;   Drug: Insulin detemir
32 Recruiting An Evaluation of Internet-based Carbohydrate Counting Education for Adolescents With Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Behavioral: In-person Carbohydrate Counting Class;   Behavioral: Online Carbohydrate Counting Tutorial
33 Recruiting Effect of a Medium Chain Triglyceride Supplemented Diet on Cognitive Function and Brain Activation in Type 1 Diabetes.
Conditions: Hypo-unawareness;   Type 1 Diabetes.
Intervention: Dietary Supplement: Medium chain triglycerides
34 Recruiting Liraglutide and Heart Failure in Type 2 Diabetes
Conditions: Congestive Heart Failure;   Type 2 Diabetes Mellitus
Interventions: Drug: liraglutide;   Drug: glimepiride;   Drug: Metformin
35 Recruiting A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Condition: Type II Diabetes Mellitus
Interventions: Drug: MK-8521;   Drug: Placebo;   Drug: Liraglutide;   Drug: Metformin
36 Recruiting Protective Effects of Saxagliptin (And Vitamin D3) on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Saxagliptin;   Drug: Vitamin D3;   Drug: Insulin
37 Recruiting A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Conditions: Type 2 Diabetes;   Chronic Kidney Disease
Interventions: Drug: Dulaglutide;   Drug: Insulin glargine;   Drug: Insulin lispro
38 Recruiting A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: SYR-472 25 mg;   Drug: Placebo + SYR-472 25 mg
39 Recruiting Intervention Using Vitamin D for Elevated Urinary Albumin Treated With Losartan in Diabetes (IDEAL)
Condition: Diabetic Nephropathies
Interventions: Dietary Supplement: Calcitriol;   Drug: Losartan
40 Recruiting Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Device: Insulin Pump;   Other: i-STAT blood testing;   Other: Blood Glucose Meter testing

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years